Shuang Wen Zhang

Director/Board Member en Xiamen LP Pharmaceutical Co., Ltd. .

53 años

Consumer Services

Health Technology

Commercial Services

Perfil

Shuang Wen Zhang is a Member-Supervisory Board at Xiamen LP Pharmaceutical Co., Ltd.
since 2020.
Previously, Zhang held the same position at Shenzhen Bioeasy Biotechnology Co. Ltd.
Zhang earned a doctorate degree from Xiamen University in 2005.

Cargos activos de Shuang Wen Zhang

Empresas	Cargo	Inicio
Xiamen LP Pharmaceutical Co., Ltd. Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China.	Director/Board Member	13/11/2020

Todos los cargos activos de Shuang Wen Zhang

Antiguos cargos conocidos de Shuang Wen Zhang.

Empresas	Cargo	Fin
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.	Director/Board Member	-

Ver el detalle de la experiencia de Shuang Wen Zhang.

Formación de Shuang Wen Zhang.

Xiamen University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Shuang Wen Zhang.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.	Health Technology

Empresas privadas	1
Xiamen LP Pharmaceutical Co., Ltd. Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China.	Commercial Services